Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ifetroban in AERD
NCT03326063Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2018
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ifetroban in Aspirin Exacerbated Respiratory Disease (AERD), sponsored by Brigham and Women's Hospital. Started Apr 2018; status: completed.
02
Drugs
ifetroban
03
Conditions
Aspirin Exacerbated Respiratory Disease (AERD)
Beyond the preview
Go deeper on NCT03326063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03326063.